Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.40
+0.11000.97%
Post-market: 11.400.00000.00%19:30 EDT
Volume:218.90K
Turnover:2.48M
Market Cap:399.77M
PE:-95
High:11.47
Open:11.29
Low:10.88
Close:11.29
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.78M
Volume Ratio:1.16
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.42
PE(LYR):-33.44

Loading ...

Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center

GlobeNewswire
·
Apr 07

Fennec Pharmaceuticals director Rosty Raykov disposes common shares worth $0.1 million

Reuters
·
Apr 03

Fennec grants 377,500 inducement stock options to 24 new employees under equity plan

Reuters
·
Apr 01

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Mar 31

Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush

TIPRANKS
·
Mar 25

Piper Sandler Sticks to Their Buy Rating for Fennec Pharmaceuticals (FENC)

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC), Talphera (TLPH) and Abivax SA Sponsored ADR (ABVX)

TIPRANKS
·
Mar 24

Fennec Pharmaceuticals Q4 GAAP EPS $(0.17) Misses $0.04 Estimate, Sales $13.777M Miss $13.993M Estimate

Benzinga Earnings
·
Mar 24

Fennec Pharma FY product sales rise 50% to record high on PEDMARK adoption

Reuters
·
Mar 24

Fennec Q4 2025 net product sales rose 75% to USD 14 million as net loss widened to USD 5 million

Reuters
·
Mar 24

Fennec Pharmaceuticals Inc - Q4 2025 Net Product Sales $13.8 Mln

THOMSON REUTERS
·
Mar 24

Fennec Pharmaceuticals FY Product Sales USD 44.6 Million

THOMSON REUTERS
·
Mar 24

Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 24

Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Benzinga Earnings
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Fennec Pharmaceuticals Inc expected to post earnings of 4 cents a share - Earnings Preview

Reuters
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026

GlobeNewswire
·
Mar 18

Fennec Pharmaceuticals Settles PEDMARK Generic Dispute With Cipla

MT Newswires Live
·
Mar 16

BRIEF-Fennec Pharmaceuticals Announces Settlement Agreement Resolving Pedmark Patent Litigation

Reuters
·
Mar 16